- Patent Title: Method of treating amyotrophic lateral sclerosis with pridopidine
-
Application No.: US16789564Application Date: 2020-02-13
-
Publication No.: US11406625B2Publication Date: 2022-08-09
- Inventor: Michal Geva , Ralph Laufer , Michael Hayden , Neta Zach
- Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
- Applicant Address: IL Herzliya
- Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
- Current Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
- Current Assignee Address: IL Herzliya
- Agency: Pearl Cohen Zedek Latzer Baratz LLP
- Agent Mark S. Cohen
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61P25/14 ; A61K9/00 ; A61K31/185 ; A61K31/222 ; A61K31/4152 ; A61K31/426 ; A61K31/4748 ; A61K31/49
Abstract:
Provided herein is a method for treating a human subject afflicted with ALS by administering to the subject a therapeutically effective amount of pridopidine as monotherapy or together with riluzole, edaravone, combination of dextromethorphan/quinidine, sodium phenylbutyrate (PB), tauroursodeoxycholic acid or combination of sodium phenylbutyrate (PB)/tauroursodeoxycholic acid (i.e. AMX0035) as combination or add-on therapy.
Public/Granted literature
- US20200179355A1 METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PRIDOPIDINE Public/Granted day:2020-06-11
Information query
